SAFETY AND HEALTH POLICY CONSIDERATIONS RELATED TO THE USE OF BUPRENORPHINE/NALOXONE AS AN OFFICE-BASED TREATMENT FOR OPIATE DEPENDENCE

Antzeko izenburuak

• PHARMACOKINETICS OF THE COMBINATION TABLET OF BUPRENORPHINE AND NALOXONE
  nork: CHIANG, C.N
• CLINICAL AND PHARMACOLOGICAL EVALUATION OF BUPRENORPHINE AND NALOXONE COMBINATIONS: WHY THE 4:1 RATIO FOR TREATMENT?
  nork: MENDELSON, J.
• BUPRENORPHINE FOR OFFICE-BASED TREATMENT OF OPIATE DEPENDENCE: US AND INTERNATIONAL FIELD EXPERIENCE
  nork: VARIOS AUTORES
• THE CLINICAL PHARMACOLOGY OF BUPRENORPHINE: EXTRAPOLATING FROM THE LABORATORY TO THE CLINIC
  nork: WALSH, S.L
• NATIONAL CLINIC GUIDELINES AND PROCEDURES FOR THE USE OF BUPRENORPHINE IN THE TREATMENT OF HEROIN DEPENDENCE
  nork: LINTZERIS, N.
  Argitaratua: (2001)